ENTRY       D08645                      Drug
NAME        Tripelennamine (INN)
FORMULA     C16H21N3
EXACT_MASS  255.1735
MOL_WEIGHT  255.358
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
REMARK      Same as: C07180
            ATC code: D04AA04 R06AC04
            Chemical structure group: DG00383
EFFICACY    Antiallergic, H1 receptor antagonist
COMMENT     Phenbenzamine derivative
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04020(3269)  Calcium signaling pathway
            hsa04080(3269)  Neuroactive ligand-receptor interaction
INTERACTION CYP inhibition: CYP2D6 [HSA:1565]
STR_MAP     map07212  Histamine H1 receptor antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
               D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
                D04AA Antihistamines for topical use
                 D04AA04 Tripelennamine
                  D08645  Tripelennamine (INN)
             R RESPIRATORY SYSTEM
              R06 ANTIHISTAMINES FOR SYSTEMIC USE
               R06A ANTIHISTAMINES FOR SYSTEMIC USE
                R06AC Substituted ethylene diamines
                 R06AC04 Tripelennamine
                  D08645  Tripelennamine (INN)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00383  Tripelennamine
                 D08645  Tripelennamine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00383  Tripelennamine
                D08645  Tripelennamine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D08645  Tripelennamine (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08645
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00383  Tripelennamine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00383  Tripelennamine
DBLINKS     CAS: 91-81-6
            PubChem: 96025328
            ChEBI: 9741
            LigandBox: D08645
            NIKKAJI: J4.349D
ATOM        19
            1   C8x C    19.3200  -16.9400
            2   C8x C    19.3200  -18.3400
            3   C8x C    20.5800  -19.0400
            4   C8x C    21.7700  -18.3400
            5   C8y C    21.7700  -16.9400
            6   C8x C    20.5800  -16.2400
            7   N5x N    22.9600  -19.0400
            8   C8y C    24.2200  -18.3400
            9   N1c N    24.2200  -16.9400
            10  C1b C    22.9600  -16.2400
            11  C8x C    22.9600  -20.4400
            12  C8x C    24.2200  -21.1400
            13  C8x C    25.4100  -20.4400
            14  C8x C    25.4100  -19.0400
            15  C1b C    25.4100  -16.2400
            16  C1b C    26.6000  -16.8700
            17  N1c N    27.7900  -16.2400
            18  C1a C    28.9800  -16.8700
            19  C1a C    27.7900  -14.7700
BOND        20
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     7   8 1
            8     8   9 1
            9     9  10 1
            10    5  10 1
            11    7  11 2
            12   11  12 1
            13   12  13 2
            14   13  14 1
            15    8  14 2
            16    9  15 1
            17   15  16 1
            18   16  17 1
            19   17  18 1
            20   17  19 1
///
